Apollomics, Inc. (NASDAQ:APLMW) Short Interest Update

Apollomics, Inc. (NASDAQ:APLMW) was the target of a large drop in short interest in February. As of February 15th, there was short interest totalling 4,400 shares, a drop of 38.9% from the January 31st total of 7,200 shares. Based on an average daily volume of 64,200 shares, the short-interest ratio is currently 0.1 days.

Apollomics Stock Performance

NASDAQ:APLMW remained flat at $0.01 on Tuesday. 13,100 shares of the company’s stock were exchanged, compared to its average volume of 23,508. The stock’s 50-day simple moving average is $0.01 and its two-hundred day simple moving average is $0.01. Apollomics has a 52 week low of $0.01 and a 52 week high of $0.03.

About Apollomics

Apollomics, Inc, a biotechnology company, engages in the discovery and development of mono and combination oncology therapies to harness the immune system and target specific molecular pathways to inhibit cancer. Its pipeline consists of various development-stage assets, including novel and humanized monoclonal antibodies that restore the body's immune system to recognize and kill cancer cells, and targeted therapies against uncontrolled growth signaling pathways.